SBI Securities’s Greenwich LifeSciences GLSI Stock Holding History

SBI Securities’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30	Closed	-$299	–	4110
2025 Q3	$299	Hold	30	–	–	﹤0.01%	3193
2025 Q2	$272	Hold	30	–	–	﹤0.01%	3216
2025 Q1	$286	Hold	30	–	–	﹤0.01%	3085
2024 Q4	$337	Buy	+30	New	+$402	﹤0.01%	3037

Other funds holding GLSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $38.1B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBI Securities's GLSI Position: Q4 2025 in Review

SBI Securities sold out of Greenwich LifeSciences (GLSI) in Q4 2025, closing a stake of 30 shares — an estimated $299 sold.

SBI Securities first reported a position in GLSI in Q4 2024 and held it in 4 quarters. The position peaked at $337 in Q4 2024. 50 funds tracked by Wall St. Rank hold GLSI as of Q4 2025.

SBI Securities reported no remaining Greenwich LifeSciences position as of Q4 2025 after selling out during the quarter.
SBI Securities sold 30 Greenwich LifeSciences shares in Q4 2025, an estimated $299.
SBI Securities first reported a position in Greenwich LifeSciences in Q4 2024 and held it in 4 quarters.
SBI Securities's Greenwich LifeSciences position peaked at $337 in Q4 2024.
50 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.